BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 16239915)

  • 41. 5'RARA submicroscopic deletion from new variant translocation involving chromosomes 15, 17, and 18, in a case of acute promyelocytic leukemia.
    Stavropoulou C; Georgakakos VN; Manola KN; Pagoni M; Garofalaki M; Pantelias GE; Sambani C
    Cancer Genet Cytogenet; 2008 Apr; 182(1):50-5. PubMed ID: 18328952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis of acute promyelocytic leukaemia by RT-PCR: detection of PML-RARA and RARA-PML fusion transcripts.
    Borrow J; Goddard AD; Gibbons B; Katz F; Swirsky D; Fioretos T; Dube I; Winfield DA; Kingston J; Hagemeijer A
    Br J Haematol; 1992 Nov; 82(3):529-40. PubMed ID: 1486033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Infrequent alterations of the RAR alpha gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines.
    Morosetti R; Grignani F; Liberatore C; Pelicci PG; Schiller GJ; Kizaki M; Bartram CR; Miller CW; Koeffler HP
    Blood; 1996 May; 87(10):4399-403. PubMed ID: 8639801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapy-induced secondary acute myeloid leukemia with t(11;19)(q23;p13.1) in a pediatric patient with relapsed acute promyelocytic leukemia.
    Dang DN; Morris HD; Feusner JH; Koduru P; Wilson K; Timmons CF; Cavalier M; Luu HS
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):e546-8. PubMed ID: 24942021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atypical response to all-trans retinoic acid in a der(5)t(5;17) acute promyelocytic leukemia.
    Mozziconacci MJ; Liberatore C; Grignani F; Sainty D; Pelicci PG; Birg F; Lafage-Pochitaloff M
    Leukemia; 1999 Jun; 13(6):862-8. PubMed ID: 10360373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
    Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
    J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
    Lo-Coco F; Hasan SK
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia.
    Glasow A; Barrett A; Petrie K; Gupta R; Boix-Chornet M; Zhou DC; Grimwade D; Gallagher R; von Lindern M; Waxman S; Enver T; Hildebrandt G; Zelent A
    Blood; 2008 Feb; 111(4):2374-7. PubMed ID: 17993618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of fluorescence in situ hybridization for detecting PML/RARA gene fusion in treated and untreated acute promyelocytic leukemia.
    Schad CR; Hanson CA; Paietta E; Casper J; Jalal SM; Dewald GW
    Mayo Clin Proc; 1994 Nov; 69(11):1047-53. PubMed ID: 7967757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of the novel deletion-type PML-RARA mutation associated with the retinoic acid resistance in acute promyelocytic leukemia.
    Hattori H; Ishikawa Y; Kawashima N; Akashi A; Yamaguchi Y; Harada Y; Hirano D; Adachi Y; Miyao K; Ushijima Y; Terakura S; Nishida T; Matsushita T; Kiyoi H
    PLoS One; 2018; 13(10):e0204850. PubMed ID: 30289902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment.
    Park DJ; Chumakov AM; Vuong PT; Chih DY; Gombart AF; Miller WH; Koeffler HP
    J Clin Invest; 1999 May; 103(10):1399-408. PubMed ID: 10330422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation.
    Vitaliano-Prunier A; Halftermeyer J; Ablain J; de Reynies A; Peres L; Le Bras M; Metzger D; de Thé H
    Blood; 2014 Dec; 124(25):3772-80. PubMed ID: 25258343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Retinoic acid receptor alpha gene rearrangement as specific marker of acute promyelocytic leukemia and its use in the study of cell differentiation].
    Zhu Y
    Zhonghua Yi Xue Za Zhi; 1992 Apr; 72(4):229-33, 255. PubMed ID: 1327453
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute Promyelocytic Leukemia with Rare Genetic Aberrations: A Report of Three Cases.
    Liu G; Liu L; Bartolo DD; Li KY; Li X
    Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RARA fusion genes in acute promyelocytic leukemia: a review.
    De Braekeleer E; Douet-Guilbert N; De Braekeleer M
    Expert Rev Hematol; 2014 Jun; 7(3):347-57. PubMed ID: 24720386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy.
    Gu BW; Xiong H; Zhou Y; Chen B; Wang L; Dong S; Yu ZY; Lu LF; Zhong M; Yin HF; Zhu GF; Huang W; Ren SX; Gallagher RE; Waxman S; Chen GQ; Wang ZG; Chen Z; Fu G; Chen SJ
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7640-5. PubMed ID: 12032336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular monitoring of minimal residual disease in acute promyelocytic leukemia by the polymerase chain reaction assay for the PML/RAR alpha (retinoic acid receptor-alpha) fusion transcript in patients treated with all-trans retinoic acid followed by chemotherapy.
    Nemet D; Grahovac B; Labar B; Mrsić M; Radman I; Bogdanić V; Hitrec V; Zaher D; Aurer I; Sertić D
    Haematologica; 1995; 80(3):238-40. PubMed ID: 7672716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid detection of PML-RARA fusion gene by novel high-speed droplet-reverse transcriptase-polymerase chain reaction: possibility for molecular diagnosis without lagging behind the morphological analyses.
    Sueki A; Matsuda K; Taira C; Yamaguchi A; Koeda H; Takagi F; Kobayashi Y; Sugano M; Honda T
    Clin Chim Acta; 2013 Jan; 415():276-8. PubMed ID: 23159843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute promyelocytic leukemia with a cryptic insertion of RARA into TBL1XR1.
    Osumi T; Watanabe A; Okamura K; Nakabayashi K; Yoshida M; Tsujimoto SI; Uchiyama M; Takahashi H; Tomizawa D; Hata K; Kiyokawa N; Kato M
    Genes Chromosomes Cancer; 2019 Nov; 58(11):820-823. PubMed ID: 31350930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and genomic characterization of an ATRA-insensitive acute promyelocytic leukemia variant with a FNDC3B::RARB fusion.
    Kirkham JK; Liu YC; Foy SG; Ma J; Gheorghe G; Furtado LV; Popescu MI; Klco JM; Karol SE; Blackburn PR
    Genes Chromosomes Cancer; 2023 Oct; 62(10):617-623. PubMed ID: 37283355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.